Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study

Abstract Background The Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical myxomatous mitral valve disease (EPIC) study monitored dogs with myxomatous mitral valve disease (MMVD) as they developed congestive heart failure (CHF). Objectives To describe the changes in clinical an...

Full description

Bibliographic Details
Main Authors: Adrian Boswood, Sonya G. Gordon, Jens Häggström, Martin Vanselow, Gerhard Wess, Rebecca L. Stepien, Mark A. Oyama, Bruce W. Keene, John Bonagura, Kristin A. MacDonald, Mark Patteson, Sarah Smith, Philip R. Fox, Karen Sanderson, Richard Woolley, Viktor Szatmári, Pierre Menaut, Whitney M. Church, M. Lynne O'Sullivan, Jean‐Philippe Jaudon, Jan‐Gerd Kresken, John Rush, Kirstie A. Barrett, Steven L. Rosenthal, Ashley B. Saunders, Ingrid Ljungvall, Michael Deinert, Eric Bomassi, Amara H. Estrada, Maria J. Fernandez Del Palacio, N. Sydney Moise, Jonathan A. Abbott, Yoko Fujii, Alan Spier, Michael W. Luethy, Roberto A. Santilli, Masami Uechi, Anna Tidholm, Christoph Schummer, Philip Watson
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.15753
_version_ 1818923170318516224
author Adrian Boswood
Sonya G. Gordon
Jens Häggström
Martin Vanselow
Gerhard Wess
Rebecca L. Stepien
Mark A. Oyama
Bruce W. Keene
John Bonagura
Kristin A. MacDonald
Mark Patteson
Sarah Smith
Philip R. Fox
Karen Sanderson
Richard Woolley
Viktor Szatmári
Pierre Menaut
Whitney M. Church
M. Lynne O'Sullivan
Jean‐Philippe Jaudon
Jan‐Gerd Kresken
John Rush
Kirstie A. Barrett
Steven L. Rosenthal
Ashley B. Saunders
Ingrid Ljungvall
Michael Deinert
Eric Bomassi
Amara H. Estrada
Maria J. Fernandez Del Palacio
N. Sydney Moise
Jonathan A. Abbott
Yoko Fujii
Alan Spier
Michael W. Luethy
Roberto A. Santilli
Masami Uechi
Anna Tidholm
Christoph Schummer
Philip Watson
author_facet Adrian Boswood
Sonya G. Gordon
Jens Häggström
Martin Vanselow
Gerhard Wess
Rebecca L. Stepien
Mark A. Oyama
Bruce W. Keene
John Bonagura
Kristin A. MacDonald
Mark Patteson
Sarah Smith
Philip R. Fox
Karen Sanderson
Richard Woolley
Viktor Szatmári
Pierre Menaut
Whitney M. Church
M. Lynne O'Sullivan
Jean‐Philippe Jaudon
Jan‐Gerd Kresken
John Rush
Kirstie A. Barrett
Steven L. Rosenthal
Ashley B. Saunders
Ingrid Ljungvall
Michael Deinert
Eric Bomassi
Amara H. Estrada
Maria J. Fernandez Del Palacio
N. Sydney Moise
Jonathan A. Abbott
Yoko Fujii
Alan Spier
Michael W. Luethy
Roberto A. Santilli
Masami Uechi
Anna Tidholm
Christoph Schummer
Philip Watson
author_sort Adrian Boswood
collection DOAJ
description Abstract Background The Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical myxomatous mitral valve disease (EPIC) study monitored dogs with myxomatous mitral valve disease (MMVD) as they developed congestive heart failure (CHF). Objectives To describe the changes in clinical and radiographic variables occurring as dogs with MMVD and cardiomegaly develop CHF, compared to similar dogs that do not develop CHF. Animals One hundred and thirty‐five, and 73 dogs that did or did not develop CHF, respectively. Materials and methods The following variables were evaluated in 2 groups of dogs (dogs that did or did not develop CHF): Heart rate (HR), clinic respiratory rate (RR), home‐measured resting respiratory rate (RRR), rectal temperature (RT), body weight (BW), and vertebral heart sum (VHS). Absolute value and rate of change of each variable were calculated for each day a dog was in study. Daily means were calculated and plotted against time. The onset of CHF or last visit before leaving the study were set as reference time points. Results The most extreme values and rate of change occurred in variables immediately before onset of CHF. Vertebral heart sum increased earliest. Heart rate, RR, and RRR also increased. Rectal temperature and BW decreased. Increases in RR and RRR were most extreme and occurred immediately before CHF. Conclusions and Clinical Importance Dogs with MMVD and cardiomegaly experience increases in HR, RR, RRR, and VHS, and decreases in BW and RT as they develop CHF. The variables with highest absolute change and rate of change were RR and RRR. These findings reinforce the value of RR and RRR as indicators of impending or incipient CHF.
first_indexed 2024-12-20T02:05:11Z
format Article
id doaj.art-f816a01d6c2348de83f7544ce3fb739b
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-12-20T02:05:11Z
publishDate 2020-05-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-f816a01d6c2348de83f7544ce3fb739b2022-12-21T19:57:14ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762020-05-013431108111810.1111/jvim.15753Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC studyAdrian Boswood0Sonya G. Gordon1Jens Häggström2Martin Vanselow3Gerhard Wess4Rebecca L. Stepien5Mark A. Oyama6Bruce W. Keene7John Bonagura8Kristin A. MacDonald9Mark Patteson10Sarah Smith11Philip R. Fox12Karen Sanderson13Richard Woolley14Viktor Szatmári15Pierre Menaut16Whitney M. Church17M. Lynne O'Sullivan18Jean‐Philippe Jaudon19Jan‐Gerd Kresken20John Rush21Kirstie A. Barrett22Steven L. Rosenthal23Ashley B. Saunders24Ingrid Ljungvall25Michael Deinert26Eric Bomassi27Amara H. Estrada28Maria J. Fernandez Del Palacio29N. Sydney Moise30Jonathan A. Abbott31Yoko Fujii32Alan Spier33Michael W. Luethy34Roberto A. Santilli35Masami Uechi36Anna Tidholm37Christoph Schummer38Philip Watson39Department of Clinical Science and Services, The Royal Veterinary College Hatfield, Hertfordshire UKDepartment of Small Animal Clinical Sciences, Texas A&M University College Station TexasDepartment of Clinical Sciences Swedish University of Agricultural Sciences Uppsala SwedenBiometrie and Statistik, Hannover GermanyClinic of Small Animal Medicine University of Munich Munich GermanySchool of Veterinary Medicine, Medical Sciences University of Wisconsin Madison Madison WisconsinClinical Studies‐Philadelphia, MJR‐VHUP‐Cardiology University of Pennsylvania Philadelphia PennsylvaniaDepartment of Clinical Sciences North Carolina State University, College of Veterinary Medicine Raleigh North CarolinaDepartment of Veterinary Clinical Sciences The Ohio State University Columbus OhioAnimal Care Center Rohnert Park CaliforniaHeartVets @ Vale Referrals, The Animal Hospital Stinchcombe, Dursley Glos UKSarah Smith Cardiology Derby UKDepartment of Cardiology and Caspary Research Institute, Animal Medical Center New York New YorkRocky Mountain Veterinary Cardiology Boulder ColoradoCardio Respiratory Pet Referrals Mordialloc, Melbourne Victoria AustraliaFaculty of Veterinary Medicine, Clinical Sciences of Companion Animals Utrecht University Utrecht The NetherlandsClinique Vétérinaire AQUIVET Eysines FranceDesert Veterinary Medical Specialists Phoenix ArizonaDepartment of Companion Animals Atlantic Veterinary College, University of Prince Edward Island Charlottetown Prince Edward Island CanadaClinique Veterinaire Des Etangs Villars Les Dombes FranceClinic for Small Animals Kaiserberg Duisburg GermanySchool of Veterinary Medicine, Clinical Sciences Tufts University Cummings North Grafton MassachusettsCardiology VCA West Los Angeles Los Angeles CaliforniaCVCA Cardiac Care for Pets Towson MarylandDepartment of Small Animal Clinical Sciences, Texas A&M University College Station TexasDepartment of Clinical Sciences Swedish University of Agricultural Sciences Uppsala SwedenFachtierarztpraxis Am Sandpfad Wiesloch GermanyCentre Hospitalier Vétérinaire des Cordeliers, Cardiology, Meaux Paris FranceUniversity of Florida College of Veterinary Medicine, Small Animal Clinical Sciences Gainesville FloridaMedicina y Cirugía Animal Universidad de Murcia Murcia SpainClinical Sciences, College of Veterinary Medicine Cornell University Ithaca New YorkDepartment of Small Animal Clinical Sciences Virginia‐Maryland College of Veterinary Medicine, Virginia Tech Blacksburg VirginiaAzabu University, Surgery 1 Kanagawa JapanBlue Pearl Veterinary Partners Tampa FloridaChicago Veterinary Emergency and Specialty Center Chicago IllinoisCardiology Clinica Veterinaria Malpensa Varese ItalyJapan Animal Specialty Medical Institute Inc., JASMINE Veterinary Cardiovascular Medical Center Yokohama JapanDjursjukhuset Albano Stockholm SwedenBoehringer Ingelheim, Animal Health Ingelheim am Rhein GermanyBoehringer Ingelheim, Animal Health Ingelheim am Rhein GermanyAbstract Background The Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical myxomatous mitral valve disease (EPIC) study monitored dogs with myxomatous mitral valve disease (MMVD) as they developed congestive heart failure (CHF). Objectives To describe the changes in clinical and radiographic variables occurring as dogs with MMVD and cardiomegaly develop CHF, compared to similar dogs that do not develop CHF. Animals One hundred and thirty‐five, and 73 dogs that did or did not develop CHF, respectively. Materials and methods The following variables were evaluated in 2 groups of dogs (dogs that did or did not develop CHF): Heart rate (HR), clinic respiratory rate (RR), home‐measured resting respiratory rate (RRR), rectal temperature (RT), body weight (BW), and vertebral heart sum (VHS). Absolute value and rate of change of each variable were calculated for each day a dog was in study. Daily means were calculated and plotted against time. The onset of CHF or last visit before leaving the study were set as reference time points. Results The most extreme values and rate of change occurred in variables immediately before onset of CHF. Vertebral heart sum increased earliest. Heart rate, RR, and RRR also increased. Rectal temperature and BW decreased. Increases in RR and RRR were most extreme and occurred immediately before CHF. Conclusions and Clinical Importance Dogs with MMVD and cardiomegaly experience increases in HR, RR, RRR, and VHS, and decreases in BW and RT as they develop CHF. The variables with highest absolute change and rate of change were RR and RRR. These findings reinforce the value of RR and RRR as indicators of impending or incipient CHF.https://doi.org/10.1111/jvim.15753caninecardiovascularclinical epidemiologyclinical trialsheart failurephysical examination
spellingShingle Adrian Boswood
Sonya G. Gordon
Jens Häggström
Martin Vanselow
Gerhard Wess
Rebecca L. Stepien
Mark A. Oyama
Bruce W. Keene
John Bonagura
Kristin A. MacDonald
Mark Patteson
Sarah Smith
Philip R. Fox
Karen Sanderson
Richard Woolley
Viktor Szatmári
Pierre Menaut
Whitney M. Church
M. Lynne O'Sullivan
Jean‐Philippe Jaudon
Jan‐Gerd Kresken
John Rush
Kirstie A. Barrett
Steven L. Rosenthal
Ashley B. Saunders
Ingrid Ljungvall
Michael Deinert
Eric Bomassi
Amara H. Estrada
Maria J. Fernandez Del Palacio
N. Sydney Moise
Jonathan A. Abbott
Yoko Fujii
Alan Spier
Michael W. Luethy
Roberto A. Santilli
Masami Uechi
Anna Tidholm
Christoph Schummer
Philip Watson
Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
Journal of Veterinary Internal Medicine
canine
cardiovascular
clinical epidemiology
clinical trials
heart failure
physical examination
title Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
title_full Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
title_fullStr Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
title_full_unstemmed Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
title_short Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
title_sort temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease the epic study
topic canine
cardiovascular
clinical epidemiology
clinical trials
heart failure
physical examination
url https://doi.org/10.1111/jvim.15753
work_keys_str_mv AT adrianboswood temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT sonyaggordon temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT jenshaggstrom temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT martinvanselow temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT gerhardwess temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT rebeccalstepien temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT markaoyama temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT brucewkeene temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT johnbonagura temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT kristinamacdonald temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT markpatteson temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT sarahsmith temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT philiprfox temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT karensanderson temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT richardwoolley temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT viktorszatmari temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT pierremenaut temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT whitneymchurch temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT mlynneosullivan temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT jeanphilippejaudon temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT jangerdkresken temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT johnrush temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT kirstieabarrett temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT stevenlrosenthal temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT ashleybsaunders temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT ingridljungvall temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT michaeldeinert temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT ericbomassi temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT amarahestrada temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT mariajfernandezdelpalacio temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT nsydneymoise temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT jonathanaabbott temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT yokofujii temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT alanspier temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT michaelwluethy temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT robertoasantilli temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT masamiuechi temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT annatidholm temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT christophschummer temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy
AT philipwatson temporalchangesinclinicalandradiographicvariablesindogswithpreclinicalmyxomatousmitralvalvediseasetheepicstudy